Horizon Pharma (NASDAQ:HZNP) reported Q4 2017 earnings this Morning, coming in at $0.29 per share, beating Wall Street’s estimates of $0.22 per Share. Revenue for the quarter came in at $274.22 million beating analyst estimates of $264.48 million Recent Insider Trading for Horizon Pharma (NASDAQ:HZNP)
- On 5/10/2017 Michael G Grey, Director, bought 10,000 with an average share price of $9.48 per share and the total transaction amounting to $94,800.00.
- On 3/1/2017 Robert Carey, EVP, sold 31,808 with an average share price of $16.03 per share and the total transaction amounting to $509,882.24.
- On 8/2/2016 Jeffrey W. Sherman, EVP, sold 2,900 with an average share price of $20.00 per share and the total transaction amounting to $58,000.00.
- On 6/15/2016 Virinder Nohria, Director, sold 25,000 with an average share price of $17.69 per share and the total transaction amounting to $442,250.00.
- On 2/26/2016 Jeffrey W Sherman, EVP, sold 4,100 with an average share price of $20.00 per share and the total transaction amounting to $82,000.00.
- On 12/10/2015 Jeffrey W Sherman, EVP, sold 4,456 with an average share price of $20.00 per share and the total transaction amounting to $89,120.00.
Recent Trading for Horizon Pharma (NASDAQ:HZNP) Shares of Horizon Pharma closed the previous trading session at 14.85 up +0.66 4.69% with 56247 shares trading hands.